|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500102539 |
|
最近更新日期: Date of Last Refreshed on: |
2025-05-15 17:37:25 |
|
注册时间: Date of Registration: |
2025-05-15 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
院内感染途径研究及继发感染的干预实验验证——病房环境中 CRAB 和 CRE 储菌源研究 |
|
Public title: |
Research on Infection Transmission Routes in Hospitals and Experimental Validation of Intervention for Secondary Infections: Study on the Storage Sources of CRAB and CRE Bacteria in Ward Environments |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
院内感染途径研究及继发感染的干预实验验证——病房环境中 CRAB 和 CRE 储菌源研究 |
|
Scientific title: |
Research on Infection Transmission Routes in Hospitals and Experimental Validation of Intervention for Hospital-Acquired Infections: Study on the Storage Sources of CRAB and CRE Bacteria in Ward Environments |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
彭雅兰 |
研究负责人: |
宗志勇 |
|
Applicant: |
Yalan Peng |
Study leader: |
Zhiyong Zong |
|
申请注册联系人电话: Applicant telephone: |
+86 153 7821 4448 |
研究负责人电话:
Study leader's |
+86 28 8542 2647 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
yalanpeng@wchscu.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
1006852844@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
四川省成都市武侯区国学巷37号 |
研究负责人通讯地址: |
国学巷37号 |
|
Applicant address: |
yalanpeng@wchscu.edu.cn |
Study leader's address: |
#37 Guoxue Lane, Wuhou District, Chengdu City, Sichuan Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
四川大学华西医院 |
||
|
Applicant's institution: |
West China Hospital of Sichuan University |
||
|
研究负责人所在单位: |
四川大学华西医院 |
||
|
Affiliation of the Leader: |
West China Hospital of Sichuan University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2025年审(731)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
四川大学华西医院生物医学伦理审查委员会 |
||
|
Name of the ethic committee: |
Ethics Committee on Biomedical Research West China Hospital of Sichuan University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-05-08 00:00:00 | ||
|
伦理委员会联系人: |
李娜 |
||
|
Contact Name of the ethic committee: |
Lina |
||
|
伦理委员会联系地址: |
国学巷37号 |
||
|
Contact Address of the ethic committee: |
#37 Guoxue Lane, Wuhou District, Chengdu City, Sichuan Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 28 8542 2654 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
188974152@qq.com |
|
研究实施负责(组长)单位: |
四川大学华西医院 |
||||||||||||||||||||||
|
Primary sponsor: |
West China Hospital of Sichuan University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
国学巷37号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
#37 Guoxue Lane, Wuhou District, Chengdu City, Sichuan Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
病原学与防疫技术体系研究 |
||||||||||||||||||||||
|
Source(s) of funding: |
Research on the System of Pathogenology and Epidemic Prevention Technology |
||||||||||||||||||||||
|
研究疾病: |
无 |
||||||||||||||||||||||
|
Target disease: |
NA |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
1.主要目的 调查本研究纳入的目标菌株,即碳青霉烯耐药肠杆菌科细菌(CRE)和碳青霉烯耐药鲍曼不动杆菌(CRAB)在医院内的环境储菌源。 明确环境储菌源与传染病患者继发相应耐药菌感染的关系。 2.次要目的 引入早期预防理念,结合环境储菌源查找结果,制定集束化防控措施。 |
||||||||||||||||||||||
|
Objectives of Study: |
1. Main purpose Investigate the environmental storage sources of the target strains included in this study, namely carbapenem resistant Enterobacteriaceae (CRE) and carbapenem resistant Acinetobacter baumannii (CRAB), in hospitals. Clarify the relationship between environmental bacterial storage sources and secondary drug-resistant bacterial infections in infectious disease patients. 2. Secondary purpose Introduce the concept of early prevention and develop bundled prevention and control measures based on the results of environmental bacterial source search. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.A.在研究期间(2025年5月1日至2025年12月31日)入住上述病房的患者。B.研究期间送检的临床样本报告有目标菌株(CRE和或CRAB)的患者。 |
||||||||||||||||||||||
|
Inclusion criteria |
1.A. Patients admitted to the aforementioned wards during the study period (May 1, 2025 to December 31, 2025). B. The clinical sample reports submitted during the study included patients with target strains (CRE and/or CRAB). |
||||||||||||||||||||||
|
排除标准: |
1.A.非研究期间内入住上述病房的患者。 B.入住上述病房前送检报阳的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.A. Patients admitted to the aforementioned wards during the non study period. B. Patients who report positive for COVID-19 before being admitted to the aforementioned wards. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-05-01 00:00:00至 To 2026-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-06-01 00:00:00 至 To 2026-06-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
NA |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表;电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF;EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |